G.A. MAKOVETSKAYA, L.I. MAZUR, M.V. KURSHINA, S.N. RESHETOVA

 Samara State Medical University, Samara

 Contact details:

Kurshina M.V. — PhD (medicine), Assistant Lecturer of the Department of Hospital Pediatrics

Address: 165А Karl Marx St., Samara, Russian Federation, 443079, tel.: +7-927-653-50-23, e-mail: marina_dmitriewa@mail.ru

 Acute post-streptococcal glomerulonephritis (APSGN) is an immune-mediated disease associated with nephritogenic strains of group A beta-hemolytic streptococcus. The epidemiology of APSGN varies in different countries, due to the influence of social, racial, demographic, and climatic conditions. In the modern spectrum of progressive diseases, APSGN occupies a modest place, yielding to other immune glomerulopathies. The prevalence rate has been declining in recent decades due to the decrease in pyoderma, however, it remains endemic to the French Polynesians and Australian Aborigines. The review defines the features of the immunological processes of this disease: nephritogens were identified at the site of the formation of immune complexes (streptococcal plasmin receptor and streptococcal pyrogenic exotoxin B). An assessment of the clinical profile of patients with APSGN (mostly asymptomatic course with a self-limiting (self-limiting) outcome) was carried out. The role of genomic surveillance in tracking potential markers of APSGN is emphasized. Risk factors for the development of kidney damage were identified — hypoalbuminemia, hypocomplementemia, and an increase in inflammatory markers. The paper considers the factors that determine the prognosis in patients, presents the main approaches to treatment (predominantly symptomatic therapy, with the exception of severe and atypical cases of the disease). It is concluded that APSGN remains one of the reasons for the development of AKI in different countries of the world. The article gives recommendations on long-term follow-up of children after APSGN.

The purpose is to analyze the prevalence and identify the factors contributing to OPSGN; to determine the specifics of the disease immunological processes of the (immunocomplexity, autoimmunity); to evaluate the clinical profile, diagnostic methods and features of OPSGN treatment; to discuss the possible progression of the disease and whether PSGN is associated with chronic kidney disease (CKD).

Key words: acute post-streptococcal glomerulonephritis, acute post-infectious glomerulonephritis, epidemiology, acute renal failure, chronic kidney disease, children.

REFERENCES

1. Ayoob R.M., Schwaderer A.L. Acute Kidney Injury and Atypical Features during Pediatric Poststreptococcal Glomerulonephritis. Int. J. Nephrol, 2016, vol. 2016, 5163065. DOI: 10.1155/2016/5163065.
2. Sharmin M., Chowdhury A.M., Ali M.A. et al. Clinical Profile and Immediate Outcome of Children Admitted with Acute Glomerulonephritis in Pediatrics Department of A Tertiary Level Hospital. Mymensingh Med. J, 2020, vol. 29 (1), pp. 5–15.
3. Skrzypczyk P., Ofiara A., Zacharzewska A. et al. Acute post-streptococcal glomerulonephritis — immune-mediated acute kidney injury — case report and literature review. Cent. Eur. J. Immunol, 2021, vol. 46 (4), pp. 516–523. DOI: 10.5114/ceji.2021.112244
4. Hunt E.A.K., Somers M.J.G. Infection-Related Glomerulonephritis. Pediatr. Clin. North Am, 2019, vol. 66 (1), pp. 59–72. DOI: 10.1016/j.pcl.2018.08.005
5. Syridou G., Drikos I., Vintila A. et al. Influenza a H1N1 associated acute glomerulonephritis in an adolescent. ID Cases, 2019, vol. 19, p. e00659. DOI: 10.1016/j.idcr.2019.e00659
6. Bhalla K., Gupta A., Nanda S. et al. Epidemiology and clinical outcomes of acute glomerulonephritis in a teaching hospital in North India. J. Family Med. Prim. Care,2019, vol. 8 (3), pp. 934–937. DOI: 10.4103/jfmpc.jfmpc_57_19
7. Stratta P., Musetti C., Barreca A. et al. New trends of an old disease: the acute post infectious glomerulonephritis at the beginning of the new millennium. J. Nephrol, 2014, vol. 27 (3), pp. 229–239. DOI: 10.1007/s40620-013-0018-z
8. Van de Voorde R.G. 3rd. Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis. Pediatr. Rev, 2015, vol. 36 (1), pp. 3–12. DOI: 10.1542/pir.36-1-3
9. Kimmel M. Infekt-assoziierte Glomerulonephritiden [Infections-associated Glomerulonephritis]. Dtsch. Med. Wochenschr, 2020, vol. 145 (4), pp. 240–247. German. DOI: 10.1055/a-0974-9420
10. Oda T., Yoshizawa N. Factors Affecting the Progression of Infection-Related Glomerulonephritis to Chronic Kidney Disease. Int. J. Mol. Sci, 2021, vol. 22 (2), pp. 905. DOI: 10.3390/ijms22020905
11. Leszczyńska A., Skrzypczyk P., Leszczyńska B. et al. Increased frequency of acute poststreptococcal glomerulonephritis in the first half of 2018 — single-center experience. Pol. Merkur. Lekarski, 2019, vol. 46 (273), pp. 115–121.
12. Rodriguez-Iturbe B., Haas M. Post-Streptococcal Glomerulonephritis. In: Ferretti J.J., Stevens D.L., Fischetti V.A., eds. Streptococcus pyogenes: Basic Biology to Clinical Manifestations. Oklahoma City (OK): University of Oklahoma Health Sciences Center, 2016.
13. Kari J.A., Bamagai A., Jalalah S.M. Severe acute post-streptococcal glomerulonephritis in an infant. Saudi J. Kidney Dis. Transpl, 2013, vol. 24 (3), pp. 546–548. DOI: 10.4103/1319-2442.111061
14. Bakr A., Mahmoud L.A., Al-Chenawi F. et al. HLA-DRB1* alleles in Egyptian children with post-streptococcal acute glomerulonephritis. Pediatr. Nephrol, 2007, vol. 22 (3), pp. 376–379. DOI: 10.1007/s00467-006-0324-y
15. Becquet O., Pasche J., Gatti H. et al. Acute post-streptococcal glomerulonephritis in children of French Polynesia: a 3-year retrospective study. Pediatr. Nephrol, 2010, vol. 25 (2), pp. 275–280. DOI: 10.1007/s00467-009-1325-4
16. Sepahi M.A., Shajari A., Shakiba M. et al. Acute glomerulonephritis: a 7 years follow up of children in center of Iran. Acta Med. Iran, 2011, vol. 49 (6), pp. 375–378.
17. Vogel A.M., Lennon D.R., van der Werf B. et al. Post-streptococcal glomerulonephritis: Some reduction in a disease of disparities. J. Paediatr. Child Health, 2019, vol. 55 (6), pp. 652–658. DOI: 10.1111/jpc.14263
18. Uchida T., Oda T. Glomerular Deposition of Nephritis-Associated Plasmin Receptor (NAPlr) and Related Plasmin Activity: Key Diagnostic Biomarkers of Bacterial Infection-related Glomerulonephritis. Int. J. Mol. Sci, 2020, vol. 21 (7), p. 2595. DOI: 10.3390/ijms21072595
19. Rodriguez-Iturbe B. Autoimmunity in Acute Poststreptococcal GN: A Neglected Aspect of the Disease. J. Am. Soc. Nephrol, 2021, vol. 32 (3), pp. 534–542. DOI: 10.1681/ASN.2020081228
20. Worthing K.A., Lacey J.A., Price D.J. et al. Systematic Review of Group A Streptococcal emm Types Associated with Acute Post-Streptococcal Glomerulonephritis. Am. J. Trop. Med. Hyg, 2019, vol. 100 (5), pp. 1066–1070. DOI: 10.4269/ajtmh.18-0827
21. Finn M.B., Ramsey K.M., Tolliver H.J. et al. Improved transformation efficiency of group A Streptococcus by inactivation of a type I restriction modification system. PLoS One, 2021, vol. 16 (4), p. e0248201. DOI: 10.1371/journal.pone.0248201
22. Akrawi D.S., Li X., Sundquist J. et al. Familial risks of glomerulonephritis — a nationwide family study in Sweden. Ann. Med, 2016, vol. 48 (5), pp. 313–322. DOI: 10.3109/07853890.2016.1169316.
23. Balasubramanian R., Marks S.D. Post-infectious glomerulonephritis. Paediatr. Int. Child. Health, 2017, vol. 37 (4), pp. 240–247. DOI: 10.1080/20469047.2017.1369642
24. DemirciogluKılıc B., Akbalık Kara M., Buyukcelik M. et al. Pediatric post-streptococcal glomerulonephritis: Clinical and laboratory data. Pediatr. Int, 2018, vol. 60 (7), pp. 645–650. doi: 10.1111/ped.13587
25. Van de Voorde R.G. 3rd. Acute poststreptococcal glomerulonephritis: the most common acute glomerulonephritis. Pediatr. Rev, 2015, vol. 36 (1), pp. 3–12. DOI: 10.1542/pir.36-1-3
26. Alayli M.B., Sanjad S.A. Severe hypoalphalipoproteinaemia in a child with acute post-streptococcal glomerulonephritis (APSGN). BMJ Case Rep, 2013, vol. 2013. bcr2013200952. DOI: 10.1136/bcr-2013-200952
27. Tasic V., Ristoska-Bojkovska N., Gucev Z. et al. Poststreptococcal glomerulonephritis in children with congenital anomalies of the kidney and urinary tract. Ren. Fail, 2015, vol. 37 (9), pp. 1440–1443. DOI: 10.3109/0886022X.2015.1074488
28. Kageyama A., Fukushima H., Usui J. et al. Poststreptococcal acute glomerulonephritis in a girl with renal cell carcinoma: possible pathophysiological association. CEN Case Rep, 2021, vol. 10 (1), pp. 139–144. DOI: 10.1007/s13730-020-00526-1
29. Gong Y.L., Li Y.F. Anticardiolipin antibodies in concurrent poststreptococcal glomerulonephritis and autoimmune hemolytic anemia: A case report. Arch. Argent. Pediatr, 2018, vol. 116 (2), pp. e288–e291. DOI: 10.5546/aap.2018.eng.e288
30. Takashima T., Hirata S., Nonaka M. et al. A rare adult case of poststreptococcal acute glomerulonephritis with a retropharyngeal abscess. CEN Case Rep, 2017, vol. 6 (1), pp. 118–123. DOI: 10.1007/s13730-017-0256-3
31. Ali el-T.M., Babikir A.M., El-Assad S. et al. Prognosis of acute post-streptococcal glomerulonephritis in Sudanese children. Arab. J. Nephrol. Transplant, 2014, vol. 7 (2), pp. 103–107.
32. Van Driel M.L., De Sutter A.I., Thorning S. et al. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst. Rev, 2021, vol. 3 (3), CD004406. DOI: 10.1002/14651858.CD004406.pub5
33. Mayer U., Bräsen J.H., Pape L. Die Rasch Progessive Glomerulonephritis im Kindesalter [Rapid Progressive Glomerulonephritis in Children]. Klin. Padiatr, 2019, vol. 231 (1), pp. 4–13. German. DOI: 10.1055/a-0669-9271
34. Chaturvedi S., Boyd R., Krause V. Acute Post-Streptococcal Glomerulonephritis in the Northern Territory of Australia: A Review of Data from 2009 to 2016 and Comparison with the Literature. Am. J. Trop. Med. Hyg, 2018, vol. 99 (6), pp. 1643–1648. DOI: 10.4269/ajtmh.18-0093
35. Davidson L., Knight J., Bowen A.C. Skin infections in Australian Aboriginal children: a narrative review. Med. J. Aust, 2020, vol. 212 (5), pp. 231–237. DOI: 10.5694/mja2.50361
36. Bertola E.A., Simonetti G.D., Del Giorno R. et al. Extrarenal Immune-Mediated Disorders Linked with Acute Poststreptococcal Glomerulonephritis: a Systematic Review. Clin. Rev. Allergy Immunol, 2019, vol. 57 (2), pp. 294–302. DOI: 10.1007/s12016-019-08761-w
37. Maalej B., Ben Amor M., Jallouli M. et al. La glomérulonéphriteaiguë post-streptococcique de l’enfant dans le sudtunisien: étude rétrospective de 12 ans. Nephrol. Ther, 2018, vol. 14 (7), pp. 518–522. DOI: 10.1016/j.nephro.2018.04.001
38. Han K.H., Lee K.H., Park S.J. et al. Hypocomplementemia (C3) as an independent predictor for children with acute post-streptococcal glomerulonephritis: a long-term observation. Eur. Rev. Med. Pharmacol. Sci, 2021, vol. 25 (18), pp. 5674–5683. DOI: 10.26355/eurrev_202109_26786
39. Limm-Chan B., Musgrave J., Lau R. et al. Incidence of Acute Post-Streptococcal Glomerulonephritis in Hawai’i and Factors Affecting Length of Hospitalization. Hawaii J. Health Soc. Welf, 2020, vol. 79 (5), pp. 149–152.
40. Gunasekaran K., Krishnamurthy S., Mahadevan S. et al. Clinical Characteristics and Outcome of Post-Infectious Glomerulonephritis in Children in Southern India: A Prospective Study. Indian J. Pediatr, 2015, vol. 82 (10), pp. 896–903. DOI: 10.1007/s12098-015-1752-0
41. Sims Sanyahumbi A., Colquhoun S., Wyber R. et al. Global Disease Burden of Group A Streptococcus. 2016 Feb 10. In: Ferretti J.J., Stevens D.L., Fischetti V.A. editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center, 2016.
42. Kanwal S., Vaitla P. Streptococcus Pyogenes. 2021 Aug 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2022 Jan. PMID: 32119415.
43. Jellouli M., Maghraoui S., Abidi K. et al. Profilévolutif de la glomérulonéphriterapidement progressive post-infectieuse de l’enfant. Nephrol. Ther, 2015, vol. 11 (6), pp. 487–491. DOI: 10.1016/j.nephro.2015.04.005
44. Rodriguez-Iturbe B., Musser J.M. The current state of poststreptococcal glomerulonephritis. J. Am. Soc. Nephrol, 2008, vol. 19 (10), pp. 1855–1864. DOI: 10.1681/ASN.2008010092
45. Hoy W.E., White A.V., Dowling A. et al. Post-streptococcal glomerulonephritis is a strong risk factor for chronic kidney disease in later life. Kidney Int, 2012, vol. 81 (10), pp. 1026–1032. DOI: 10.1038/ki.2011.478
46. Calderon-Margalit R., Golan E., Twig G. et al. History of Childhood Kidney Disease and Risk of Adult End-Stage Renal Disease. N. Engl. J. Med, 2018, vol. 378 (5), pp. 428–438. DOI: 10.1056/NEJMoa1700993
47. Vernon K.A., Goicoechea de Jorge E., Hall A.E. et al. Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency. Am. J. Kidney Dis, 2012, vol. 60 (1), pp. 121–125. DOI: 10.1053/j.ajkd.2012.02.329
48. Serrano Viñuales I., Ruiz Del OlmoIzuzquiza I., Romero Salas Y. et al. Glomerulonefritisrápidamenteprogresiva de etiologíaposinfecciosa. Caso pediátrico [Postinfectious rapidly progressive glomerulonephritis in a pediatric patient]. Arch. Argent. Pediatr., 2019, Aug. 1, vol. 117(4), pp. e363–e367. doi: 10.5546/aap.2019.e363.
49. Ishiko S., Horinouchi T., Fujimaru R. et al. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases. Sci. Rep, 2020, vol. 10 (1), p. 14026. DOI: 10.1038/s41598-020-71101-y
50. Kusano T., Takano H., Kang D. et al. Endothelial cell injury in acute and chronic glomerular lesions in patients with IgA nephropathy. Hum. Pathol, 2016, vol. 49, pp. 135–144. DOI: 10.1016/j.humpath.2015.10.013
51. Su Q., Liang Y., Wang N.A. et al. Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience. Turk. J. Med. Sci, 2021, vol. 51 (5), pp. 2683–2689. DOI: 10.3906/sag-2104-319
52. Ye M., Wang C., Li L. et al. The influences of α-hemolytic Streptococcus on class switching and complement activation of human tonsillar cells in IgA nephropathy. Immunol. Res, 2022, vol. 70 (1), pp. 86–96. DOI: 10.1007/s12026-021-09223-2
53. Cambier A., Gleeson P.J., Flament H. et al. New therapeutic perspectives for IgA nephropathy in children. Pediatr. Nephrol, 2021, vol. 36 (3), pp. 497–506. DOI: 10.1007/s00467-020-04475-w
54. Caravaca-Fontán F., Lucientes L., Cavero T. et al. Update on C3 Glomerulopathy: A Complement-Mediated Disease. Nephron, 2020, vol. 144 (6), pp. 272–280. DOI: 10.1159/000507254
55. Zahir Z., Wani A.S., Gupta A. et al. Pediatric C3 glomerulopathy: a 12-year single-center experience. Pediatr. Nephrol, 2021, vol. 36 (3), pp. 601–610. DOI: 10.1007/s00467-020-04768-0
56. Trutin I., Oletić L., Galešić Ljubanović D. et al. A child with dense deposit disease and decreased classic complement pathway activity. Acta Clin. Croat, 2021, vol. 60 (1), pp. 141–145. DOI: 10.20471/acc.2021.60.01.21
57. Wang R., Wang M., Xia Z. et al. Long-term renal survival and related risk factors for primary membranous nephropathy in Chinese children: a retrospective analysis of 217 cases. J. Nephrol, 2021, vol. 34 (2), pp. 589–596. DOI: 10.1007/s40620-020-00816-y
58. Mosaad F.G., Saggaf O.M., Aletwady K.T. et al. Assessment of the etiologies and renal outcomes of rapidly progressive glomerulonephritis in pediatric patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. Saudi Med. J, 2018, vol. 39 (4), pp. 354–360. DOI: 10.15537/smj.2018.4.21366
59. Wenderfer S.E., Ruth N.M., Brunner H.I. Advances in the care of children with lupus nephritis. Pediatr. Res, 2017, vol. 81 (3), pp. 406–414. DOI: 10.1038/pr.2016.247
60. Muthu V., Ramachandran R., Nada R. et al. Clinicopathological Spectrum of Glomerular Diseases in Adolescents: A Single-center Experience over 4 Years. Indian J. Nephrol, 2018, vol. 28 (1), pp. 15–20. DOI: 10.4103/ijn.IJN_239_16
61. Davin J.C., Coppo R. Henoch-Schönlein purpura nephritis in children. Nat. Rev. Nephrol, 2014, vol. 10 (10), pp. 563–573. DOI: 10.1038/nrneph.2014.126
62. Vaz A.S., Penteado R., Cordinhã C. et al. IgA vasculitis (Henoch-Schönlein purpura) nephritis and psoriasis in a child: is there a relationship? J. Bras. Nefrol, 2021, vol. 43 (4), pp. 603–607. DOI: 10.1590/2175-8239-JBN-2020-0101
63. Pillebout E., Sunderkötter C. IgA vasculitis. Semin. Immunopathol, 2021, vol. 43 (5), pp. 729–738. DOI: 10.1007/s00281-021-00874-9